The Journal of Experimental Medicine
ImmunoPrecise
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
Published online
doi:10.1084/jem.20071401
The Journal of Experimental Medicine, Vol. 204, No. 11, 2545-2552
The Rockefeller University Press, 0022-1007 $30.00
© Kaplan et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 2448K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kaplan, D. H.
Right arrow Articles by Shlomchik, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kaplan, D. H.
Right arrow Articles by Shlomchik, M. J.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

BRIEF DEFINITIVE REPORT

 Autocrine/paracrine TGFß1 is required for the development of epidermal Langerhans cells

Daniel H. Kaplan1, Ming O. Li3, Matthew C. Jenison1, Warren D. Shlomchik3,4, Richard A. Flavell3, and Mark J. Shlomchik2,3

1 Department of Dermatology, 2 Department of Laboratory Medicine, 3 Section of Immunobiology, and 4 Section of Medical Oncology, Yale University School of Medicine, New Haven, CT 06520

CORRESPONDENCE Daniel H. Kaplan: dankaplan{at}umn.edu

Langerhans cells (LCs) are bone marrow (BM)–derived epidermal dendritic cells (DCs) that develop from precursors found in the dermis. Epidermal LCs are absent in transforming growth factor (TGF) ß1-deficient mice. It is not clear whether TGFß1 acts directly on LC precursors to promote maturation or whether it acts on accessory cells, which in turn affect LC precursors. In addition, the physiologic source of TGFß1 is uncertain because BM chimera experiments showed that neither hematopoietic nor nonhematopoietic-derived TGFß1 is required for LC development. To address these issues, we created mice transgenic for a bacterial artificial chromosome (BAC) containing the gene for human Langerin into which Cre recombinase had been inserted by homologous recombination (Langerin-Cre). These mice express Cre selectively in LCs, and they were bred to floxed TGFßRII and TGFß1 mice, thereby generating mice with LCs that either cannot respond to or generate TGFß1, respectively. Langerin-Cre TGFßRII mice had substantially reduced numbers of epidermal LCs, demonstrating that TGFß1 acts directly on LCs in vivo. Interestingly, Langerin-Cre TGFß1 mice also had very few LCs both in the steady state and after BM transplantation. Thus, TGFß1 derived from LCs acts directly on LCs through an autocrine/paracrine loop, and it is required for LC development and/or survival.

Abbreviations used: BAC, bacterial artificial chromosome; CSF, colony-stimulating factor; EGFP, enhanced GFP; HSC, hematopoietic stem cell; LC, Langerhans cell.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS